InVivo Therapeutics stock sinks after 1-for-25 reverse stock split announced

InVivo Therapeutics Holdings Corp. said Thursday it will carry out a 1-for-25 reverse stock split, which is intended to increase the per-share trading price of its stock and fulfill the Nasdaq Capital Market's $1 minimum bid price requirement.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.